Johansson Peter L, Safai-Kutti Soodabeh, Kutti Jack
Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Goteborg, Sweden.
Br J Haematol. 2005 Jun;129(5):701-5. doi: 10.1111/j.1365-2141.2005.05517.x.
The diagnosis of polycythaemia vera (PV) has been established upon sets of clinical criteria, which require the presence of absolute erythrocytosis (AE). The most recent clinical criteria for PV, published by the World Health Organization (WHO) in 2001, also required AE, and stated that the measured red cell mass (RCM) could be replaced by a surrogate marker for AE; a haemoglobin (Hb) value of >18.5 g/dl in males and >16.5 g/dl in females. The present study evaluated the potential of venous haematocrit (Hct) and Hb values as possible surrogate markers for AE in a series of 77 consecutive patients with PV and 66 patients with apparent polycythaemia (AP), in all of whom the RCM had been previously determined. In only 35% of the male PV patients would Hb values >18.5 g/dl indicate the presence of AE. Conversely, 14% of male AP patients would be misdiagnosed as having AE. A Hb > 16.5 g/dl would predict the presence of AE in 63% of the female PV patients, but 35% of female AP cases would be misdiagnosed as having AE. However, when the Hct was > or =0.60 an AE was always present, and this was true for both male and female subjects.
真性红细胞增多症(PV)的诊断是基于一系列临床标准确立的,这些标准要求存在绝对红细胞增多症(AE)。世界卫生组织(WHO)于2001年发布的最新PV临床标准也要求有AE,并指出测得的红细胞容量(RCM)可用AE的替代标志物替代;男性血红蛋白(Hb)值>18.5 g/dl,女性>16.5 g/dl。本研究评估了静脉血细胞比容(Hct)和Hb值作为AE可能替代标志物的潜力,研究对象为77例连续的PV患者和66例表观红细胞增多症(AP)患者,所有患者之前均已测定RCM。仅35%的男性PV患者Hb值>18.5 g/dl表明存在AE。相反,14%的男性AP患者会被误诊为有AE。Hb>16.5 g/dl可预测63%的女性PV患者存在AE,但35%的女性AP病例会被误诊为有AE。然而,当Hct≥0.60时总是存在AE,男性和女性受试者均如此。